-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
As a global leader in life science research and clinical diagnostic products, BIO-rad Laboratories (NYSE: BIO and BIOb) today announced that after meeting the CE-IVD marking requirements, it will launch Reliance SARS-CoV-2/ for the European market.
Reliance SARS-CoV-2/FluA/FluB? RT-PCR kit (IVD) is a single-molecule detection kit designed for COVID-19 detection in clinical diagnostic laboratories
"In the coming influenza season, the COVID-19 pandemic continues, and many countries are opening up and returning to work, clinicians need a sensitive, reliable and convenient way to detect common respiratory viruses and distinguish cases of COVID-19 infection, which does not involve Influenza or influenza B infection," said Steven Black, Bio-Rad Global Marketing Director, Life Sciences Group, Gene Expression
Please visitto learn more about Reliance SARS-CoV-2/FluA/FluB? RT-PCR kit (IVD)
BIO-RAD, Reliance SARS-CoV-2/FluA/FluB and CFX96 are trademarks of BIO-RAD Laboratories in certain jurisdictions
About Bio-Rad
BIO-rad Laboratories, Inc.